Medicaid coverage practices for approved gene and cell therapies: Existing barriers and proposed policy solutions

Medicaid coverage practices for approved gene and cell therapies: Existing barriers and proposed policy solutions

The current Medicaid system is ill equipped to handle the anticipated approvals of new gene and cell therapy products. These advanced therapies tend to be single-dose, potentially durable options for a variety of indications spanning oncology, rare disease, and more. The up-front cost of these thera...

Full description

Bibliographic Details
Main Authors: Jeremy Allen, Diane Berry, Francesca Cook, Ashley Hume, Rayne Rouce, Anirudh Srirangam, Jennifer Wellman, Caitlin McCombs
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Molecular Therapy: Methods & Clinical Development
Subjects:
Medicaid
payment policy
CMS
cell therapy
gene therapy
value-based payment
Online Access:http://www.sciencedirect.com/science/article/pii/S2329050123000773

Internet

http://www.sciencedirect.com/science/article/pii/S2329050123000773

Similar Items